News

As per the terms of the agreement, Abbott is expected to make milestone payments and pay royalties to Lipocine based upon product sales. Abbott is responsible for all

The recommendation was made following discussions with Cell Therapeutics about the preclinical and clinical Pixantrone data, including PIX301, and the desire to explore the potential benefits pixantrone may

The study, titled ‘TLE3 expression is predictive of response to chemotherapy in NSCLC,’ included 368 samples from carcinoma patients. Clarient said that the majority of advanced-stage patients who

GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity. Acorda Therapeutics had submitted an IND

EMD Chemicals said that the StemSelect Library I is an expert selection of 303 pharmacologically active, cell-permeable (or cell receptor binding) InSolution modulators, many of which act in

Immunomedics had recently developed a new serum-based enzyme immunoassay (ELISA) for early diagnosis of pancreatic cancer, employing clivatuzumab that has a sensitivity of 62% for detecting stage-1 pancreatic

The new test is based upon a plasma biomarker discovered by R&D Antibodies that forecasts the onset of the sepsis pathology. In previous clinical studies the test was

ForteBio claimed that Octet QK(e) system would enable biosensors to be re-racked, for increased workflow flexibility and cost savings. ForteBio has also introduced latest Anti-Penta-HIS (HIS) biosensors for

Mr Guay is a chartered accountant since 1974 and has a number of years of experience in business management. During his career, he has worked for such companies